US$ 27.16
glp-1 and dpp4 Inhibitors vs Agonists | June 2021 | Clinical Corner Frontiers | Physiology and Pharmacology
Description
Talk with your doctor about bariatric surgery or GLP-1 medication

doi: 10.24875/RCCAR.24000056 74 CoxZLCollinsSPHernandezGAMcRaeATDavidsonBTAdamsKet al

Endocrinology 14112281235

Durch diesen Energieverlust nehmen die Patienten ungefhr 2 kg ab

Patients should have thyroid function monitored during substantial weight loss, with dose adjustments based on TSH and FT4 results
